Company intelligence / Profile preview

AlphaThera

Philadelphia, Pennsylvania, United Statesalphathera.com ↗

Ownership: Private
Development stage: Commercial

Overview

AlphaThera has launched over 15 different products and serves clients both domestically and worldwide. Their products enable site-specific antibody labeling for various applications including high-sensitivity ELISAs, flow cytometry, and single-cell analysis[1].

Modalities: Antibody labeling reagents
Industry: Non-Drug Biotech

Drug pipeline

2 assets

oYo-Link SureLight APC

Commercial

Indications: Research use only

1 more asset in the full pipeline.

Request access →

Partnerships

Columbia Biosciences

Beyond the preview

Go deeper on AlphaThera.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AlphaThera.

Explore the full profile